As of November 6, 2026, Firefly Neuroscience, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on September 14, 2026 (Form 8-K, September 14, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Firefly Neuroscience, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Firefly Neuroscience, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-09-14. Every row below is cited to the filing it comes from, and this page adds each new change as Firefly Neuroscience, Inc. files it.
Also on the record for Firefly Neuroscience, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 16, 2026 | Form D, private offering | $2.25M sold | Form D page | Source |
| January 30, 2026 | Stake report, Schedule 13D/A, by Windsor Private Capital LP | 5% of the class | 5%+ stakes | Source |
| December 31, 2025 | Stake report, Schedule 13D/A, by Windsor Private Capital LP | 6.1% of the class | 5%+ stakes | Source |
| December 9, 2025 | Stake report, Schedule 13D/A, by Windsor Private Capital LP | 7.5% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Arena Investors, LP | — | 5%+ stakes | Source |
| November 7, 2025 | Stake report, Schedule 13D/A, by Windsor Private Capital LP | 8.7% of the class | 5%+ stakes | Source |
| October 23, 2025 | Stake report, Schedule 13D/A, by Windsor Private Capital LP | 9.7% of the class | 5%+ stakes | Source |
| October 15, 2025 | Stake report, Schedule 13D/A, by Windsor Private Capital LP | 11.3% of the class | 5%+ stakes | Source |
| June 23, 2025 | Form D, private offering | $1.20M sold | Form D page | Source |
Selling to them or working with them? See who runs Firefly Neuroscience, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Firefly Neuroscience, Inc. and the records around it.
Firefly Neuroscience, Inc. elsewhere on the record
- Company profile and every filing Apr 2026
- Form D filing Apr 2026
- 5%+ stake filings Jan 2026
- Form D filing Jun 2025
- Who owns it
Companies that share a holder
- Arena Investors, LP also filed stake reports on 10 other companies: RenX Enterprises Corp. (Feb 2026), RYVYL Inc. (Feb 2026), OceanPal Inc. (Nov 2025)
Watch Firefly Neuroscience, Inc.
Get an email when Firefly Neuroscience, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Firefly Neuroscience, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Firefly Neuroscience, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Firefly Neuroscience, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-14 | Reported | not named in the filing | 8-K, 2026-09-14 |
New leaders reset buying decisions — get the Full Report on Firefly Neuroscience, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportWatch Firefly Neuroscience, Inc. (free up to 3)
Find people with the same kind of experience as the senior executive at Firefly Neuroscience, Inc., with the record behind each one.
Find candidates like senior executive at Firefly Neuroscience, Inc.Every change, in the filing's words
Reported
On September 8, 2026, the board of directors (the "Board") of Firefly Neuroscience, Inc., a Delaware corporation (the "Company"), terminated Paul Krzywicki as Chief Financial Officer of the Company, effective September 24, 2026.
- Mr. Krzywicki's termination was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- On the same date, the Nominating and Corporate Governance Committee of the Board recommended the appointment of Jessica Paz as Chief Accounting Officer of the Company, and the Board approved Ms. Paz's appointment as Chief Accounting Officer of the Company.
- On September 8, 2026, the Compensation Committee of the Board approved and ratified an offer of employment extended to Ms. Paz, dated July 28, 2026 (the "Paz Offer of Employment").
- Under the Paz Offer of Employment, Ms. Paz was employed as the Company's Chief Accounting Officer effective September 8, 2026, at an annual base salary of $215,000.
- Pursuant to the Paz Offer of Employment, Ms. Paz was granted a stock option to purchase 50,000 shares of common stock of the Company under the Firefly Neuroscience, Inc. 2024 Long-Term Incentive Plan (as amended, the "Plan") and the form of the stock option agreement approved for grants under the Plan, at an exercise price per share equal to the fair market value of the Company's common stock on the date of grant.
Firefly Neuroscience, Inc.'s funding history
Tools for this story
Each opens in a new tab, filled in for Firefly Neuroscience, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.